Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran

Pakistan Journal of Biological Sciences

Volumn 12, Issue 14, 2009, Pages 1012-1018

  Zakizad, M ^a   Salmeh, F ^a   Yaghoobi, T ^a   Yaghoubian, Z ^a   Nesami, M B ^a   Esmaeeli, Z ^a   Vaezzadeh, N ^a   Shahmohammadi, S ^a   Modanloo, S ^a   Sadeghian, A A ^a   Abdolmanafi, S J ^b   Mohammadpour, R A ^a   Siamian, H ^c   Khosravi, A ^d  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Yasouj University of Medical Sciences ^*

^c YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Faculty of Medicine   (Iran)

Author keywords

Addicts; Hepatitis C; Prisoner; Seroprevalence

Indexed keywords

HEPATITIS C VIRUS;

HEPATITIS C ANTIBODY;

ADDICTION; ADULT; ARTICLE; BLOOD; EPIDEMIOLOGY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; IRAN; MALE; MIDDLE AGED; PRISONER; RISK FACTOR;

ADULT; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IRAN; MALE; MIDDLE AGED; PRISONERS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 73949120268     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.1012.1018     Document Type: Article

References (36)

1. Abrignani, S., M. Houghton and H.H. Hsu, 1999. Perspectives for a vaccine against hepatitis C virus. J Hepatol., 31: 259-263.
2. Alavian, S.M. and S.H. Sall, 2000. Review of hepatitis C and approach to it. J. Medical Council of Islamic Republic of Iran, 1379, 18: 49-64 (In Persian).
3. Allen, S.A., A.C. Spaulding, A.M. Osei, L.E. Taylor, A.M. Cabral and J.D. Rich, 2003a. Treatment of chronic hepatitis C in a state correctional facility. Ann. Intern. Med., 138: 187-190.
4. Allen, S.A., J.D. Rich, B. Schwartzapfel and P.D. Friedmann, 2003. Hepatitis C among offenders-correctional challenge and public health opportunity. Federal Prob., 67: 22-26.
5. Allwright, S., F. Bradley, J. Long, J. Barry, S.R. Reynolds, L. Thornton and J.V. Parry, 2000. Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. BMJ., 321: 78-82.
6. Babudieri, S., B. Longo, L. Sarmati, G. Starnini, L. Dori, B. Suligoi and S. Carbonara et al., 2005. Correlates of I H V, HBV and H CV infections in a prison inmate population: Results from a multicentre study in Italy. J. Med. Virol., 76: 311-117.
7. Batyrov, F.A., O.P. Frolova, G.N. Zhukova, I.G. Sementsova and O.I. Mukhanova, 2003. A cotegory of patients with tuberculosis concomitant with HIV infection in an anti-TB facility. Prob. 1 Tuberk Bolezn Legk., 5: 6-9.
8. Birchard, K., 2001. Europe-wide survey finds widespread drug abuse in prisons. The Lancet., 358: 821-821
9. Birchard, K., 2003. Drug use in prisons a major medical problem. Med. Post., 39: 68-68.
10. Bogaerts, J., J. Ahmed, N. Akhter, N. Begum, M. Van Ranst and J. Verhaegen, 2000. Sexually transmitted infections among married women in Dhaka Bangladesh: Unexpected high prevalence of herpes simplex type 2 infection. Sex Transm. Infect., 77: 114-119.
11. Burattini, M., E. Massad, M. Rozman, R. Azevedo and H. Carvalho, 2000. Correlation between HIV and HCV in Brazilian prisoners: Evidence for parenteral transmission inside prison. Rev. Saude. Publica., 34: 431-436.
12. Ciancio, A., P. Manzini, F. Castagno, S. D'Antico and P. Reynaudo et al., 2005. Digestive endos copy is not a major risk factor for transmitting hepatitis c virus. Ann. Intern. Med., 142: 903-909.
13. De Groot, A. S. and J. Bick, 2000. The correctional doctor's dilemma: Hepatitis C treatment. HEPP News., 3: 1-9.
14. Degos, F., 1999. Hepatitis C and alchol. J. Hepatol., 1: 113-118.
15. Fox, R.K., S.L. Currie, J. Evans, T.L. Wright, L. Tobler, B. Phelps and M.P. Busch et al., 2005. Hepatitis C virus infection among prisoners in the California state correctional system. Clin. Infect. Dis., 41: 177-186.
16. Hagan, H. and D.C. Des-Jarlais, 2000. HIV and HCV infection among injecting drug users. Mt. Sinai. J. Med., 67: 423-428.
17. Hand, W.L. and Y. Vasquez, 2005. Risk factors for hepatitis C on the Texas-Mexico border. Am. J. Gastroenterol., 100: 2180-2185.
18. Hellard, M.E., J.S. Hocking and N. Crofts, 2004. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol. Infect., 132: 409-415.
19. Holford, T.R., 2002. Multivariate Methods in Epidemiology. Oxford University Press, New York, pp: 440.
20. Ibrahimi D.N., S.H. Mirmoamen, A.A. Hashtroudi, H. Bahraini and A. Habibi, 2001. Viral hepatitis (part two). J. Med. Purification, 42: 44-55 (In Persian).
21. Ibrahimi, D.N., S.H. Mirmoamen, A.A. Hashtroudi, H. Bahraini and A. Habibi, 2001. Viral hepatitis (part one). J. Med. Purification, 41: 61-70 (In Persian).
22. Kane, A., J. Lloyd, M. Zaffran, L. Simonsen and M. Kane, 1999. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: Model-based regional estimates. Bull World Health Organ., 77: 801-807.
23. Khani, M. and M.M. Vakili, 2003. The study of HIV, HBV and HCV prevalence rates in addicted male prisoners in central prison of Zanjan city. Zanjan University of Medical Sciences, pp: 111 (In Persian).
24. Mohammad Alizadeh, A.H., M. Alavian, K.H. Jafari and N. Yazdi, 2005. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran. World J. Gastroenterol., 11: 4085-4089.
25. Mohsen, A.H., 2001. The epidemiology of hepatitis C in a UK health regional population of 5. 12 million. Gut., 48: 707-713.
26. Patrick, D.M., J.A. Buxton, M. Bigham and R.G. Mathias, 2000. Public health and hepatitis C. Can. J. Public Health, 91: 519-523.
27. Perez, C.M., E. Suarez, E.A. Torres, K. Roman and V. Colon, 2005. Seroprevalence of hepatitis C virus and associated risk behaviours: A population-based study in San Juan, Puerto Rico. Int. J. Epidemiol., 34: 593-599.
28. Puro, V., G. De Carli., P. Scognamiglio, R. Porcasi and G. Ippolito, 2001. Risk of HIV and other blood-borne infections in the cardiac setting: Patient-to-provider and provider-to-patient transmission. Ann. N.Y. Acad. Sci., 946: 291-309.
29. Reindollar, R.W., 1999. Hepatitis C and the correctional population. Am. J. Med., 107: 1005-1035.
30. Sabbatani, S., R. Giuliani, C. Fulgaro, P. Paolillo, E. Baldi and F. Chiodo, 2004. HIV Ab, HCV Ab and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counseling on the compliance of proposed tests. Epidemiol. Prev., 28: 163-168.
31. Sadeghi, A., M. Shariatzadeh and M. Lameie, 1998. The study of HCV prevalence among blood donors in Urmia blood transfusion center. J. Urmia Univ. Med. Sci., 9: 242-247 (In Persian).
32. Shaw-Stiffel, ThA, 2000. Chronic Hepatitis. In: Principles and Practice of Infectious Diseases, Mandell, G., J. Bennett and R. Dolin (Eds.). 5th Edn., Churchill Livingstone, Philadelphia, pp: 1307-1319
33. Taylor, A., D. Goldberg, S. Hutchinson, S. Cameron and S.M. Gore et al., 2000. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1995: Are current harm reduction strategies working?. J. Infect., 40: 176-183.
34. Touzet, S., L. Kraemer, C. Colin, P. Pradat and D. Lanoir et al., 2000. Epidemiology of hepatitis C virus infection in seven European union countries: A critical analysis of the literature. Eur. J. Gastroenterol. Hepatol., 12: 667-678.
35. Yildirim, B., V. Tahan, R. Ozaras, H. Aytekin, A. Mert, F. Tabak and H. Senturk, 2005. Hepatitis C virus risk factors in the Turkish community. Dig. Dis. Sci., 50: 2352-2355.
36. Zali, M.R., A. Noroozi, H. Amirrasooli and M. Darvishi, 1998. Prevalence of Anti-HCV antibody and routes of hematological transmission in addicts of Ghasr prison. Pejouhesh, 22: 26-26 (In Persian).